Variant report
Variant | nsv974289 |
---|---|
Chromosome Location | chr14:80911851-80915626 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:80913917..80916409-chr14:80918301..80920954,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs539162461 | chr14:80911932-80911933 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190769655 | chr14:80911967-80911968 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs77437109 | chr14:80911970-80911971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534024304 | chr14:80912008-80912009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555361998 | chr14:80912017-80912018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs28502765 | chr14:80912022-80912023 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs142861861 | chr14:80912081-80912082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538400252 | chr14:80912097-80912098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571120516 | chr14:80912113-80912114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs578126137 | chr14:80912131-80912132 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs56876627 | chr14:80912133-80912134 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs180824417 | chr14:80912161-80912162 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs184667668 | chr14:80912162-80912163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs146734073 | chr14:80912163-80912164 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs116856852 | chr14:80912186-80912187 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs531892741 | chr14:80912193-80912194 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs79049512 | chr14:80912221-80912222 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs139273085 | chr14:80912236-80912237 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs532791913 | chr14:80912270-80912271 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs370076814 | chr14:80912297-80912298 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551045390 | chr14:80912299-80912300 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs566600604 | chr14:80912372-80912373 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113550880 | chr14:80912456-80912457 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs188364960 | chr14:80912462-80912463 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144158051 | chr14:80912490-80912491 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs553553571 | chr14:80912539-80912540 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146503841 | chr14:80912561-80912562 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs556528541 | chr14:80912611-80912612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs578060032 | chr14:80912617-80912618 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs370323252 | chr14:80912680-80912681 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553972640 | chr14:80912691-80912692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs181233285 | chr14:80912733-80912734 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375036267 | chr14:80912758-80912759 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542814224 | chr14:80912827-80912828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561546881 | chr14:80912853-80912854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs531856405 | chr14:80912869-80912870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs543685089 | chr14:80912972-80912973 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572227712 | chr14:80912978-80912979 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs565270300 | chr14:80913000-80913001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs558474326 | chr14:80913095-80913096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs574604210 | chr14:80913132-80913133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs149670045 | chr14:80913134-80913135 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs372102844 | chr14:80913135-80913136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs10664034 | chr14:80913144-80913145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs4016516 | chr14:80913147-80913148 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2059967 | chr14:80913156-80913157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs58744906 | chr14:80913293-80913294 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs566395036 | chr14:80913334-80913335 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200016585 | chr14:80913364-80913365 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112363755 | chr14:80913418-80913419 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
cataract | 16735990 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16608533 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma | 21080181 | CNVD |
Gastric cancer | 16891809 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:80902000-80913400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr14:80905800-80916800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr14:80911800-80912400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr14:80912000-80912400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr14:80912000-80912400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr14:80912000-80912400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr14:80912000-80912600 | Enhancers | H9 Cell Line | embryonic stem cell |
8 | chr14:80912000-80912600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr14:80912200-80912400 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
10 | chr14:80912200-80912600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr14:80912200-80912600 | Enhancers | H1 Cell Line | embryonic stem cell |
12 | chr14:80912200-80912600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
13 | chr14:80912200-80914400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
14 | chr14:80912400-80913800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr14:80912600-80912800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
16 | chr14:80912600-80913400 | Enhancers | NHDF-Ad | bronchial |
17 | chr14:80913400-80914000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
18 | chr14:80915200-80919400 | Weak transcription | Skeletal Muscle Male | skeletal muscle |